Rare exonic variant affects GRN splicing and contributes to frontotemporal lobar degeneration

Neurobiol Aging. 2023 Oct:130:61-69. doi: 10.1016/j.neurobiolaging.2023.06.009. Epub 2023 Jun 16.

Abstract

Heterozygous loss-of-function (LOF) mutations in the progranulin gene (GRN) cause frontotemporal lobar degeneration (FTLD) by a mechanism of haploinsufficiency. For most missense mutations, the contribution to FTLD is however unclear. We studied the pathogenicity of rare GRN missense mutations using patient biomaterials. We identified a new mutation in GRN, c.1178 A>C, in a patient with a diagnosis of primary progressive aphasia. Neuropathological examination of autopsied brain showed FTLD with TAR DNA-binding protein 43 (FTLD-TDP) type A pathology with concomitant Alzheimer's disease pathology. Serum progranulin protein levels were reduced to levels comparable to known LOF mutations. The mutation is in the last codon of exon 10, in the splice donor sequence. Our data provide evidence that the mutation leads to aberrant splicing, resulting in a frameshift (p.(Glu393AlafsTer31)) and consequently nonsense-mediated mRNA decay. Our finding demonstrates that carefully examining sequencing data around splice sites is needed since this mutation was annotated as a missense mutation. Unraveling the pathogenicity of variants of unknown significance is important for clinical diagnosis and genetic counseling.

Keywords: Frontotemporal dementia; Frontotemporal lobar degeneration with TAR DNA-binding protein 43 pathology (FTLD-TDP); Loss-of-function; Progranulin (PGRN); Rare variants.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exons / genetics
  • Frontotemporal Dementia* / genetics
  • Frontotemporal Lobar Degeneration* / pathology
  • Humans
  • Intercellular Signaling Peptides and Proteins / genetics
  • Mutation / genetics
  • Progranulins / genetics

Substances

  • Progranulins
  • Intercellular Signaling Peptides and Proteins
  • GRN protein, human